LOGIN  |  REGISTER
Recursion
Recursion

Veeva Systems to Release Fiscal 2024 Second Quarter Results on August 30, 2023

August 08, 2023 | Last Trade: US$224.15 4.48 2.04

PLEASANTON, Calif., Aug. 8, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its second quarter, which ended July 31, 2023, after market close on August 30, 2023. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results.

Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event.

Event:       

Veeva's Fiscal 2024 Second Quarter Results Conference Call

Date:         

Wednesday, August 30, 2023

Time:         

2:00 p.m. PT (5:00 p.m. ET)

Conference Call Registration:

https://conferencingportals.com/event/badXudFz

Webcast:   

ir.veeva.com

About Veeva Systems

Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Veeva uses its ir.veeva.com website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor Veeva's investor relations website in addition to following its press releases, SEC filings, and public conference calls and webcasts.

Investor Relations Contact:

  

Gunnar Hansen

Veeva Systems Inc.

267-460-5839

This email address is being protected from spambots. You need JavaScript enabled to view it.

  

Media Contact:

 

Maria Scurry

 

Veeva Systems Inc.

 

781-366-7617

 

This email address is being protected from spambots. You need JavaScript enabled to view it. 

 

Stock Quote

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB